GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuso Pharmaceutical Industries Ltd (TSE:4538) » Definitions » Total Assets

Fuso Pharmaceutical Industries (TSE:4538) Total Assets : 円77,709 Mil (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Fuso Pharmaceutical Industries Total Assets?

Fuso Pharmaceutical Industries's Total Assets for the quarter that ended in Dec. 2023 was 円77,709 Mil.

During the past 12 months, Fuso Pharmaceutical Industries's average Total Assets Growth Rate was 9.50% per year. During the past 3 years, the average Total Assets Growth Rate was 1.40% per year. During the past 5 years, the average Total Assets Growth Rate was -0.60% per year. During the past 10 years, the average Total Assets Growth Rate was 0.20% per year.

During the past 13 years, Fuso Pharmaceutical Industries's highest 3-Year average Total Assets Growth Rate was 3.10%. The lowest was -4.90%. And the median was -0.15%.

Total Assets is connected with ROA %. Fuso Pharmaceutical Industries's annualized ROA % for the quarter that ended in Dec. 2023 was 2.65%. Total Assets is also linked to Revenue through Asset Turnover. Fuso Pharmaceutical Industries's Asset Turnover for the quarter that ended in Dec. 2023 was 0.20.


Fuso Pharmaceutical Industries Total Assets Historical Data

The historical data trend for Fuso Pharmaceutical Industries's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuso Pharmaceutical Industries Total Assets Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71,687.00 69,153.00 69,876.00 69,334.00 72,466.00

Fuso Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72,994.00 72,466.00 74,746.00 76,274.00 77,709.00

Fuso Pharmaceutical Industries Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Fuso Pharmaceutical Industries's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (A: Mar. 2023 )+Total Liabilities (A: Mar. 2023 )
=35649+36817
=72,466

Fuso Pharmaceutical Industries's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=36077+41632
=77,709

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuso Pharmaceutical Industries  (TSE:4538) Total Assets Explanation

Total Assets is connected with ROA %.

Fuso Pharmaceutical Industries's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=2040/( (76274+77709)/ 2 )
=2040/76991.5
=2.65 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Fuso Pharmaceutical Industries's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=15406/( (76274+77709)/ 2 )
=15406/76991.5
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Fuso Pharmaceutical Industries Total Assets Related Terms

Thank you for viewing the detailed overview of Fuso Pharmaceutical Industries's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuso Pharmaceutical Industries (TSE:4538) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid.

Fuso Pharmaceutical Industries (TSE:4538) Headlines

No Headlines